MétaCan
Menu
Back to cohort
Record W3170456976 · doi:10.1093/infdis/jiab305

Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics Summit

2021· article· en· W3170456976 on OpenAlexaff
Matthew D. Hall, James M. Anderson, Annaliesa S. Anderson, David Baker, Jay Bradner, Kyle R. Brimacombe, Elizabeth A. Campbell, Kizzmekia S. Corbett, Kara Carter, Sara Cherry, Lillian Chiang, Tomáš Cihlář, Emmie de Wit, Mark R. Denison, Matthew D. Disney, Courtney V. Fletcher, Stephanie L. Ford‐Scheimer, Matthias Götte, A Grossman, Frederick G. Hayden, Daria J. Hazuda, Charlotte Lanteri, Hilary D. Marston, Andrew D. Mesecar, Stephanie Moore, Jennifer O. Nwankwo, Jules O’Rear, George R. Painter, Kumar Singh Saikatendu, Celia A. Schiffer, Timothy P. Sheahan, Pei‐Yong Shi, Hugh D. C. Smyth, Michael J. Sofia, Marla Weetall, Sandra K. Weller, Richard J. Whitley, Anthony S. Fauci, Christopher P. Austin, Francis S. Collins, Anthony J. Conley, Mindy I. Davis

Bibliographic record

VenueThe Journal of Infectious Diseases · 2021
Typearticle
Languageen
FieldMedicine
TopicSARS-CoV-2 and COVID-19 Research
Canadian institutionsUniversity of Alberta
FundersNational Center for Advancing Translational SciencesNational Institute of Allergy and Infectious DiseasesNational Institutes of Health
KeywordsSummitCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Antiviral drug2019-20 coronavirus outbreakMedicineDrug discoveryPublic healthDrug developmentPandemicPolitical scienceDiseaseVirologyInfectious disease (medical specialty)DrugPharmacologyBioinformaticsVirusBiologyGeography

Abstract

fetched live from OpenAlex

The NIH Virtual SARS-CoV-2 Antiviral Summit, held on 6 November 2020, was organized to provide an overview on the status and challenges in developing antiviral therapeutics for coronavirus disease 2019 (COVID-19), including combinations of antivirals. Scientific experts from the public and private sectors convened virtually during a live videocast to discuss severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) targets for drug discovery as well as the preclinical tools needed to develop and evaluate effective small-molecule antivirals. The goals of the Summit were to review the current state of the science, identify unmet research needs, share insights and lessons learned from treating other infectious diseases, identify opportunities for public-private partnerships, and assist the research community in designing and developing antiviral therapeutics. This report includes an overview of therapeutic approaches, individual panel summaries, and a summary of the discussions and perspectives on the challenges ahead for antiviral development.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.018
metaresearch head score (Gemma)0.009
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Other · Consensus signal: none
Teacher disagreement score0.023
Threshold uncertainty score0.094

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0180.009
Meta-epidemiology (narrow)0.0020.001
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0020.002
Science and technology studies0.0030.001
Scholarly communication0.0060.003
Open science0.0020.005
Research integrity0.0070.008
Insufficient payload (model declined to judge)0.0170.008

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.065
GPT teacher head0.386
Teacher spread0.322 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreOther

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations41
Published2021
Admission routes1
Has abstractyes

Explore more

Same venueThe Journal of Infectious DiseasesSame topicSARS-CoV-2 and COVID-19 ResearchFrench-language works237,207